January/February 2021 Supplement
Vitreous Opacities
Current trends and treatment strategies
Edwin H. Ryan, MD; Tarek S. Hassan, MD; S.K. Steven Houston III, MD; John W. Kitchens, MD; John Pollack, MD; and Christina Y. Weng, MD, MBA
November/December 2020 | Special Report
The Winning Pitch Challenge: Helping Innovators in the Trenches
How to birth the next great innovation in retina.
Daniel L. Chao, MD, PhD
April 2020 | Special Report
The Winning Pitch Challenge
A resource for innovative retina specialists who need a helping hand.
An Interview With John Pollack, MD
October 2013 | Retina Business
Making the Most of EHR Data
Why you should maintain control of your data and capture more of its economic value.
David F. Williams, MD, MBA; Nicholas G. Anderson, MD; and John Pollack, MD
October 2013 | Retina Business
Making the Most of EHR Data
Why you should maintain control of your data and capture more of its economic value.
David F. Williams, MD, MBA; Nicholas G. Anderson, MD; and John Pollack, MD
June 2010 Supplement
Coming Into Focus: Molecular Mechanisms of Glucocorticoid Action in the Eye
Robert H. Oakley, PHD, and John A. Cidlowski, PHD
April 2010 | Medical Retina
Patient Assessment: Gel vs Liquid Anesthetic for Intravitreal Injections
There was a high degree of patient satisfaction with the procedure.
John S. Pollack, MD, and Michael J. Davis, MD
September 2009 | Meeting News
RETINAWS: ARVO Update
Kourous A. Rezaei, MD
